Skip to main content
SpringerLink
Log in

Authors’ Reply to Uguen: “Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma”

  • Letter to the Editor
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

The Original Article was published on 19 September 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Uguen. Comment on: “Comparison of five different assays for the detection of BRAF mutations in formalin-fixed paraffin embedded tissues of patients with metastatic melanoma”. Mol Diagn Ther. 2017. doi:10.1007/s40291-017-0300-1.

  2. Franczak C, Salleron J, Dubois C, Filhine-Tresarrieu P, Leroux A, et al. Comparison of five different assays for the detection of BRAF mutations in formalin-fixed paraffin embedded tissues of patients with metastatic melanoma. Mol Diagn Ther. 2017;21(2):209–16.

    Article  CAS  PubMed  Google Scholar 

  3. French Ministère des solidarités et de la santé. Le référentiel des actes innovants hors nomenclature de biologie et d’anatomocytopathologie (RIHN). 2017. Available at: http://solidarites-sante.gouv.fr/systemede-sante-et-medico-social/recherche-et-innovation/rihn.

  4. Swanton C, Soria JC, Bardelli A, Biankin A, Caldas C, et al. Consensus on precision medicine for metastatic cancers: a report from the MAP conference. Ann Oncol. 2016;27(8):1443–8.

    Article  CAS  PubMed  Google Scholar 

  5. Harle A, Salleron J, Franczak C, Dubois C, Filhine-Tressarieu P, et al. Detection of BRAF mutations using a fully automated platform and comparison with high resolution melting, real-time allele specific amplification, immunohistochemistry and next generation sequencing assays, for patients with metastatic melanoma. PloS One. 2016;11(4):e0153576.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Université de Lorraine, Nancy, France

    Alexandre Harlé & Claire Franczak

  2. CNRS, UMR 7039 CRAN, Nancy, France

    Alexandre Harlé & Claire Franczak

  3. Service de Biopathologie, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, CS30519, Vandoeuvre-lès-Nancy Cedex, France

    Alexandre Harlé & Claire Franczak

Authors
  1. Alexandre Harlé
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire Franczak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexandre Harlé.

Ethics declarations

Conflict of interest

Alexandre Harlé and Claire Franczak declare no conflicts of interest.

Funding

No sources of funding were used in the preparation of this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harlé, A., Franczak, C. Authors’ Reply to Uguen: “Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma”. Mol Diagn Ther 21, 695–696 (2017). https://doi.org/10.1007/s40291-017-0301-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40291-017-0301-0

Search

Navigation